Activation of TNF receptor 2 in microglia promotes induction of anti-inflammatory pathways

Molecular and Cellular Neuroscience

Volumn 45, Issue 3, 2010, Pages 234-244

  Veroni, Caterina ^a   Gabriele, Lucia ^a   Canini, Irene ^a   Castiello, Luciano ^a   Coccia, Eliana ^a   Remoli, Maria Elena ^a   Columba Cabezas, Sandra ^a   Aricò, Eleonora ^a   Aloisi, Francesca ^a   Agresti, Cristina ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Cytokine receptors; Cytokines; Glial cells; Inflammation; Microarrays

Indexed keywords

ADRENOMEDULLIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MESSENGER RNA; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ARTICLE; BRAIN INFECTION; BRAIN INJURY; CELL FUNCTION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; INFLAMMATION; INNATE IMMUNITY; MICROARRAY ANALYSIS; MICROGLIA; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; MICE; MICROARRAY ANALYSIS; MICROGLIA; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956615515     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2010.06.014     Document Type: Article

References (71)

1. Aderka D., Engelmann H., Maor Y., Brakebusch C., Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 1992, 175:323-329.
2. Agresti C., Bernardo A., Del Russo N., Marziali G., Battistini A., Aloisi F., Levi G., Coccia E.M. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. Eur. J. Neurosci. 1998, 10:2975-2983.
3. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G., Probert L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 1998, 153:801-813.
4. Aloisi F. Immune function of microglia. Glia 2001, 36:165-179. (Review).
5. Aloisi F., De Simone R., Columba-Cabezas S., Levi G. Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J. Neurosci. Res. 1999, 56:571-580.
6. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 2001, 4:1116-1122.
7. Baud V., Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001, 11:372-377. (Review).
8. Bette M., Kaut O., Schäfer M.K., Weihe E. Constitutive expression of p55TNFR mRNA and mitogen-specific up-regulation of TNF alpha and p75TNFR mRNA in mouse brain. J. Comp. Neurol. 2003, 465:417-430.
9. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 1996, 2:788-794.
10. Carballo E., Blackshear P.J. Roles of tumor necrosis factor-alpha receptor subtypes in the pathogenesis of the tristetraprolin-deficiency syndrome. Blood 2001, 98:2389-2395.
11. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
12. Chen X., Bäumel M., Männel D.N., Howard O.M., Oppenheim J.J. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 2007, 179:154-161.
13. Chen X., Subleski J.J., Kopf H., Howard O.M., Männel D.N., Oppenheim J.J. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+ CD25+ FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J. Immunol. 2008, 180:6467-6471.
14. Delgado M., Ganea D. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav. Immun. 2008, 22:1146-1151.
15. Dickensheets H.L., Freeman S.L., Smith M.F., Donnelly R.P. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood 1997, 90:4162-4171.
16. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor. necrosis factor receptors in rat glia. J. Neuroimmunol. 1997, 75:104-112.
17. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2. J. Neurosci. 2002, 22:RC216.
18. Gioannini T.L., Teghanemt A., Zhang D., Prohinar P., Levis E.N., Munford R.S., Weiss J.P. Endotoxin-binding proteins modulate the susceptibility of bacterial endotoxin to deacylation by Acyloxyacyl Hydrolase. J. Biol. Chem. 2007, 282:7877-7884.
19. Gonzalez P., Burgaya F., Acarin L., Peluffo H., Castellano B., Gonzalez B. Interleukin-10 and interleukin-10 receptor-I are upregulated in glial cells after an excitotoxic injury to the postnatal rat brain. J. Neuropathol. Exp. Neurol. 2009, 68:391-403.
20. Grell M., Becke F.M., Wajant H., Männel D.N., Scheurich P. TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur. J. Immunol. 1998, 28:257-263.
21. Grell M., Wajant H., Zimmermann G., Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc. Natl Acad. Sci. USA 1998, 95:570-575.
22. Hasselblatt M., Jeibmann A., Riesmeier B., Maintz D., Schäbitz W.R. Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol. 2007, 113:45-51.
23. Hinson J.P., Kapas S., Smith D.M. Adrenomedullin, a multifunctional regulatory peptide. Endocr. Rev. 2000, 21:138-167. (Review).
24. Jin L., Raymond D.P., Crabtree T.D., Pelletier S.J., Houlgrave C.W., Pruett T.L., Sawyer R.G. Enhanced murine macrophage TNF receptor shedding by cytosine-guanine sequences in oligodeoxynucleotides. J. Immunol. 2000, 165:5153-5160.
25. Joyce D.A., Steer J.H. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes. Cytokine 1996, 8:49-57.
26. Kim K.Y., Kim M.Y., Choi H.S., Jin B.K., Kim S.U., Lee Y.B. Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release. NeuroReport 2002, 13:849-852.
27. Kohno T., Brewer M.T., Baker S.L., Schwartz P.E., King M.W., Hale K.K., Squires C.H., Thompson R.C., Vannice J.L. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl Acad. Sci. USA 1990, 87:8331-8335.
28. Kraft A.D., McPherson C.A., Harry G.J. Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology 2009, 30:785-793.
29. Kurlander R.J., Ellison D.M., Hall J. The blockade of Fc receptor-mediated clearance of immune complexes in vivo by a monoclonal antibody (2.4G2) directed against Fc receptors on murine leukocytes. J. Immunol. 1984, 133:855-862.
30. Lai W.S., Carballo E., Strum J.R., Kennington E.A., Phillips R.S., Blackshear P.J. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol. Cell. Biol. 1999, 19:4311-4323.
31. Lambertsen K.L., Clausen B.H., Fenger C., Wulf H., Owens T., Dagnaes-Hansen F., Meldgaard M., Finsen B. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 2007, 144:934-949.
32. Ledeboer A., Brevé J.J., Wierinckx A., van der Jagt S., Bristow A.F., Leysen J.E., Tilders F.J., Van Dam A.M. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 2002, 16:1175-1185.
33. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
34. Luo D., Luo Y., He Y., Zhang H., Zhang R., Li X., Dobrucki W.L., Sinusas A.J., Sessa W.C., Min W. Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am. J. Pathol. 2006, 169:1886-1898.
35. MacEwan D.J. TNF ligands and receptors-a matter of life and death. Br. J. Pharmacol. 2002, 135:855-875. (Review).
36. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell. Signal. 2002, 14:477-492. (Review).
37. Mackay F., Rothe J., Bluethmann H., Loetscher H., Lesslauer W. Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. J. Immunol. 1994, 153:5274-5284.
38. Marchetti L., Klein M., Schlett K., Pfizenmaier K., Eisel U.L. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 2004, 279:32869-32881.
39. Mason A.T., McVicar D.W., Smith C.A., Young H.A., Ware C.F., Ortaldo J.R. Regulation of NK cells through the 80-kDa TNFR (CD120b). J. Leukoc. Biol. 1995, 58:249-255.
40. Miyashita K., Itoh H., Arai H., Suganami T., Sawada N., Fukunaga Y., Sone M., Yamahara K., Yurugi-Kobayashi T., Park K., Oyamada N., Sawada N., Taura D., Tsujimoto H., Chao T.H., Tamura N., Mukoyama M., Nakao K. The neuroprotective and vasculo-neuro-regenerative roles of adrenomedullin in ischemic brain and its therapeutic potential. Endocrinology 2006, 147:1642-1653.
41. Mohler K.M., Torrance D.S., Smith C.A., Goodwin R.G., Stremler K.E., Fung V.P., Madani H., Widmer M.B. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 1993, 151:1548-1561.
42. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophages activation. Nat. Rev. Immunol. 2008, 8:958-969.
43. Nadeau S., Rivest S. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 1999, 93:1449-1464.
44. Park P.H., Huang H., McMullen M.R., Mandal P., Sun L., Nagy L.E. Suppression of Lipopolysaccharide-stimulated tumor necrosis factor-production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 2008, 283:26850-26858.
45. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
46. Rauert H., Wicovsky A., Mueller N., Siegmund D., Spindler V., Waschke J., Kneitz C., Wajant H. Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J. Biol. Chem. 2010, 285:7394-7404.
47. Rodriguez M., Zoecklein L., Papke L., Gamez J., Denic A., Macura S., Howe C. Tumor necrosis factor alpha is reparative via TNFR1 in the hippocampus and via TNFR2 in the striatum after virus-induced encephalitis. Brain Pathol. 2009, 19:12-26.
48. Sauer I., Schaljo B., Vogl C., Gattermeier I., Kolbe T., Müller M., Blackshear P.J., Kovarik P. Interferons limit inflammatory responses by induction of tristetraprolin. Blood 2006, 107:4790-4797.
49. Schaljo B., Kratochvill F., Gratz N., Sadzak I., Sauer I., Hammer M., Vogl C., Strobl B., Müller M., Blackshear P.J., Poli V., Lang R., Murray P.J., Kovarik P. Tristetraprolin is required for full anti-inflammatory response of murine macrophages to IL-10. J. Immunol. 2009, 183:1197-1206.
50. Schneider A., Kuhn H.G., Schäbitz W.R. A role for G-CSF (granulocyte-colony stimulating factor) in the central nervous system. Cell Cycle 2005, 4:1753-1757. (Review).
51. Seitz C., Männel D.N., Hehlgans T. Isolation and functional characterization of the mouse p75 TNF receptor promoter. Genomics 1998, 48:111-116.
52. Seo D.R., Kim K.Y., Lee Y.B. Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion. NeuroReport 2004, 15:1157-1161.
53. Serrano J., Alonso D., Encinas J.M., Lopez J.C., Fernandez A.P., Castro-Blanco S., Fernández-Vizarra P., Richart A., Bentura M.L., Santacana M., Uttenthal L.O., Cuttitta F., Rodrigo J., Martinez A. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience 2002, 109:717-731.
54. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 1999, 10:119-130. (Review).
55. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962. (Review).
56. Sriram K., O'Callaghan J.P. Divergent roles for tumor necrosis factor-alpha in the brain. J. Neuroimmune Pharmacol. 2007, 2:140-153. (Review).
57. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 2002, 16:1474-1476.
58. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha. FASEB J. 2006, 20:670-682.
59. Taoufik E., Petit E., Divoux D., Tseveleki V., Mengozzi M., Roberts M.L., Valable S., Ghezzi P., Quackenbush J., Brines M., Cerami A., Probert L. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc. Natl Acad. Sci. USA 2008, 105:6185-6190.
60. Tesz G.J., Guilherme A., Guntur K.V., Hubbard A.C., Tang X., Chawla A., Czech M.P. Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2. J. Biol. Chem. 2007, 282:19302-19312.
61. Tixier E., Leconte C., Touzani O., Roussel S., Petit E., Bernaudin M. Adrenomedullin protects neurons against oxygen glucose deprivation stress in an autocrine and paracrine manner. J. Neurochem. 2008, 106:1388-1403.
62. Unkeless J.C. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 1979, 150:580-596.
63. Van Mierlo G.J., Scherer H.U., Hameetman M., Morgan M.E., Flierman R., Huizinga T.W., Toes R.E. Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 2008, 180:2747-2751.
64. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc. Natl Acad. Sci. USA 1992, 89:4845-4849.
65. Vercammen D., Vandenabeele P., Declercq W., Van de Craen M., Grooten J., Fiers W. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Cytokine 1995, 7:463-470.
66. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003, 10:45-65. (Review).
67. Xia C.F., Yin H., Borlongan C.V., Chao J., Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum. Gene Ther. 2004, 15:1243-1254.
68. Xia C.F., Yin H., Borlongan C.V., Chao J., Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Exp. Neurol. 2006, 197:521-530.
69. Xiao B.G., Lu C.Z., Link H. Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection. J. Cell. Mol. Med. 2007, 11:1272-1290. (Review).
70. Xu J., Chakrabarti A.K., Tan J.L., Ge L., Gambotto A., Vujanovic N.L. Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood 2007, 109:3333-3341.
71. Zhang R., Xu Y., Ekman N., Wu Z., Wu J., Alitalo K., Min W. Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J. Biol. Chem. 2003, 278:51267-51276.